Newsroom

Cardiac Insight Appoints Renowned Cardiologist Dr. Victor Froelicher as New Chief Medical Officer

Seattle, WA – [8/5/2024] – Cardiac Insight, a leading innovator in advanced...

Cardiac Insight Sponsors Free Health Fair Hosted by

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

FEATURED NEWS

Cardea 20/20

A Pioneering Solution Engineered for an Athlete's Heart, Developed by Renowned Dr. David Hadley, CTO of Cardiac Insight & Dr. Vic Frolicher, Professor of Medicine & Consultant in Sports Cardiology at Stanford Healthcare

12.15.23

Corporate

Boilerplate of Cardiac Insight

12.15.23

Corporate

Cardiac Insight Achieves Remarkable Sales Team Expansion, Signaling Rapid Growth and Market Expansion

11.11.23

American Football Championship. Teams Ready: Professional Players, Aggressive Face-off, Ready for Pushing, Tackling. Competition Full of Brutal Energy, Power

Product

College Athletic Organizations Using Cardea 20/20 ECG

11.08.23

Corporate

Dan Tylutki Assumes the Role of Chief Operating Officer at Cardiac Insight

09.19.22

Product

Abnormal electrocardiographic findings in athletes: recognising changes suggestive of primary electrical disease

01.01.22

Product

Abnormal electrocardiographic findings in athletes: recognising changes suggestive of cardiomyopathy

01.01.22

Product

The prevalence and prognostic significance of electrocardiographic abnormalities

01.01.22

Cardea SOLO

Cardea SOLO™ Captures AFIB On Day 3

01.01.22

Cardea 20/20

College of Southern Nevada (CSN) to become the first school in Las Vegas to Mandate Heart Screening in its Athletics Program and Opens Doors to the Community for Free Event.

07.31.24

Cardea 20/20

Vegas Has a Heart Joins Forces with Shaq to School to Promote Sudden Cardiac Arrest Awareness

07.17.24

Cardea 20/20

Vegas Has a Heart Announces Exciting Collaboration with Gatorade 2023-24 Boys Basketball Player of the Year, Xavion Stanton

05.28.24

Cardea 20/20

Cardiac Insight Continues to Champion Athletes’ Heart Health with Successful Heart Screening Event at Davante Adams Football Camp

04.14.24

Cardea 20/20

Vegas Has a Heart First Heart Screening Event powered by Who We Play For and Cardiac Insight, Official ECG Provider, Showcases the Impact of Early Detection

03.23.24

Cardea 20/20 Press Release Product

A Pioneering Solution Engineered for an Athlete’s Heart, Developed by Renowned Dr. David Hadley, CTO of Cardiac Insight & Dr. Vic Frolicher, Professor of Medicine & Consultant in Sports Cardiology at Stanford Healthcare

12.15.23

Corporate

Boilerplate of Cardiac Insight

12.15.23

Corporate

Cardiac Insight Achieves Remarkable Sales Team Expansion, Signaling Rapid Growth and Market Expansion

11.11.23

Corporate

Cardiac Insight Sponsors VPASC’s Annual Health Fair, Aiding in Cardiovascular Education and Community Health

11.05.23

Corporate

Cardiac Insight Welcomes Cori Graham as the New Product Manager.

11.01.23

Corporate

Cardiac Insight Experiences Remarkable Growth with Key Additions to Engineering Team.

10.15.23

Corporate

Cardiac Insight launches “CI Heart to Heart Talk” YouTube Channel Hosted by Dani Reeves: A Groundbreaking Platform Redefining Cardiology Discussions.

10.12.23

Corporate

Cardiac Insight Welcomes Amy Moon as Chief Sales Officer (CSO).

04.02.23

Corporate

Roy Kim Elevated to President & Chief Growth Officer (CGO) at Cardiac Insight

04.02.23

Corporate

Dr. Dave Hadley Elevates Role to Chief Technology Officer (CTO) at Cardiac Insight

09.19.22

Corporate

Dan Tylutki Assumes the Role of Chief Operating Officer at Cardiac Insight

09.19.22

Corporate

Cardiac Insight Welcomes Roy Kim as CFO Following Acquisition by Dreamtech

04.04.22

Corporate

Dreamtech Acquires Cardiac Insight, A Strategic Move to Expand into the Heart Health Market

03.14.22

Cardea SOLO

Cardea SOLO™ Captures AFIB On Day 3

01.01.22

Cardea 20/20

The impact of ST elevation on athletic screening

09.11.21

Cardea SOLO

New Onset AF Detected Early By Cardea SOLO™, Facilitating Anticoagulation And Reducing Stroke Risk

10.21.20

Cardea SOLO

Interventional Cardiologist Uses Cardea SOLOTM Wearable ECG Sensor To Diagnose Early Onset Atrial Fibrillation In A Cardiology Clinic Setting

07.18.20

Cardea SOLO

Primary Care Practice Detects AF With Cardea SOLO Resulting In Seamless T

05.05.20

Cardea 20/20

QT Corrections for Long QT Risk Assessment: Implications for the Pre-participation Examination. Hadley, David PhD; Hsu, David BS; Pickham, David PhD; Drezner, Jonathan A. MD; Froelicher, Victor F. MD

07.01.19

Cardea 20/20

Natural history of the electrocardiographic pattern of early repolarization in ambulatory patients

12.15.15

Cardea 20/20

Prognostic value of electrocardiographic criteria for left ventricular hypertrophy

07.01.15

Cardea 20/20

Prognostic importance of isolated T-wave abnormalities

01.15.15

Cardea 20/20

The Prognostic Value of T Wave Amplitude in Lead aVR in Males

03.12.13

Cardea 20/20

Normal electrocardiographic findings: recognizing physiological adaptations in athletes

01.09.13

Cardea 20/20

Electrocardiographic interpretation in athletes: the ‘Seattle Criteria’

01.09.13

Cardea 20/20

Semantic Confusion: The Case of Early Repolarization and the J Point

02.14.12

Cardea 20/20

The Effect of Sport on Computerized Electrocardiogram Measurements in College Athletes

02.09.12

Cardea 20/20

Early repolarization in an ambulatory clinical population

11.15.11

Cardea 20/20

A novel method for patient-specific QTc–modeling QT-RR hysteresis.

01.16.11

Cardea 20/20

Interpretation of the electrocardiogram of young athletes

08.09.10

Cardea 20/20

An evidence-based review of the resting electrocardiogram as a screening technique for heart disease

07.01.10

Cardea 20/20

The prognostic importance of isolated P-Wave abnormalities

06.10.10

Cardea 20/20

Effect of gender on computerized electrocardiogram measurements in college athletes

06.01.10

Cardea 20/20

T-wave abnormalities are a better predictor of cardiovascular mortality than ST depression on the resting electrocardiogram

04.10.10

Cardea 20/20

Addition of the electrocardiogram to the preparticipation examination of college athletes

03.20.10

Cardea 20/20

Cost-effectiveness of pre-participation screening for prevention of sudden cardiac death in young athletes.

03.02.10

Cardea 20/20

Prognostic Significance of Quantitative QRS Duration

04.01.07

Cardea 20/20

Electrocardiographic arrhythmia risk testing

07.01.04

Cardea 20/20

Prognostic significance of PVCs and resting heart rate

04.13.04

All Cardea 20/20 Cardea SOLO Corporate

Press Resources

MEDIA/PRESS KIT

Cardiac Insight’s comprehensive media kit for in-depth information on the company and its technology and innovations.

MEDIA CONTACT

Corporate Communications (US)

MEDIA LIBRARY

Explore our media library for brand assets, videos, featured images, and more.

Newsroom

FEATURED NEWS

Cardiac Insight Sponsors Free Health Fair Hosted by

FEATURED NEWS

Press Resources

Cardea SOLO

Cardea 20/20

Insights

Other Pages